FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112775495> ?p ?o ?g. }

• W2112775495 abstract "Thioacetamide (TA), a potent centrilobular hepatotoxicant, undergoes a two-step bioactivation mediated by microsomal CYP2E1 to TA sulfoxide (TASO), and further to TA-S,S-dioxide (TASO2), a reactive metabolite that initiates cellular necrosis. Our earlier studies showed that bioactivation-mediated liver injury of TA is not dose-proportional. The objective of this study was to examine whether increasing doses of TA lead to enzyme saturation, thereby resulting in lack of dose-response for injury: bioactivation of TA --> TASO --> TASO2 may follow zero-order kinetics. A 12-fold dose range of TA (50, 300, and 600 mg/kg i.p.) was injected into male Sprague-Dawley rats. TA and TASO were quantified in plasma, liver, and urine by high-performance liquid chromatography. With increasing doses, the apparent elimination half-lives of TA and TASO increased linearly, indicating that TA bioactivation exhibits saturation kinetics. Increasing TA dose resulted in greater-than-proportional increases in plasma TA and TASO levels. The TASO/TA ratio was inversely proportional to the dose of TA. Covalent binding of 14C-TA-derived radiolabel to liver macromolecules showed a less-than-dose-proportionate increase with a 12-fold higher dose. Less than dose-proportional covalent binding was confirmed in liver microsomal incubations with 14C-TA. Three-fold higher excretion of TASO was seen in urine at the highest dose (600 mg/kg) compared with the lowest dose (50 mg TA/kg). Incubation of TA with rat liver microsomes and purified baculovirus-expressed rat and human CYP2E1 Supersomes, over a concentration range of 0.01 to 10 mM, revealed saturation of TA conversion to TASO at and above 0.05 mM TA concentration, comparable to in vivo plasma and liver levels achieved upon administration of higher doses. Calculated K(m) values for TA (0.1 mM) and TASO (0.6 mM) suggest that the second step of TA bioactivation is 6-fold less efficient. Collectively, the findings indicate saturation of CYP2E1 at the first (TA to TASO) and second (TASO to TASO2) steps of TA bioactivation." @default.
• W2112775495 created "2016-06-24" @default.
• W2112775495 creator A5008224944 @default.
• W2112775495 creator A5013354704 @default.
• W2112775495 creator A5034466779 @default.
• W2112775495 creator A5035081477 @default.
• W2112775495 creator A5073343840 @default.
• W2112775495 date "2005-09-23" @default.
• W2112775495 modified "2023-10-01" @default.
• W2112775495 title "SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY" @default.
• W2112775495 cites W139856755 @default.
• W2112775495 cites W1524754033 @default.
• W2112775495 cites W1539778282 @default.
• W2112775495 cites W1567011157 @default.
• W2112775495 cites W1779976310 @default.
• W2112775495 cites W1846124876 @default.
• W2112775495 cites W1901655084 @default.
• W2112775495 cites W1964257589 @default.
• W2112775495 cites W1969480997 @default.
• W2112775495 cites W1979312677 @default.
• W2112775495 cites W1980644479 @default.
• W2112775495 cites W1982558668 @default.
• W2112775495 cites W2031239009 @default.
• W2112775495 cites W2033017391 @default.
• W2112775495 cites W2058413466 @default.
• W2112775495 cites W2058574887 @default.
• W2112775495 cites W2068396499 @default.
• W2112775495 cites W2082129971 @default.
• W2112775495 cites W2091223805 @default.
• W2112775495 cites W2100439404 @default.
• W2112775495 cites W2113685352 @default.
• W2112775495 cites W2124345456 @default.
• W2112775495 cites W2125369485 @default.
• W2112775495 cites W2128635872 @default.
• W2112775495 cites W2142085135 @default.
• W2112775495 cites W2152999460 @default.
• W2112775495 cites W2156827860 @default.
• W2112775495 cites W2160643235 @default.
• W2112775495 cites W2314933133 @default.
• W2112775495 cites W2344852776 @default.
• W2112775495 cites W2395427226 @default.
• W2112775495 cites W2415801349 @default.
• W2112775495 cites W2417710438 @default.
• W2112775495 cites W2423612804 @default.
• W2112775495 cites W53503538 @default.
• W2112775495 cites W72705406 @default.
• W2112775495 doi "https://doi.org/10.1124/dmd.105.005520" @default.
• W2112775495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16183780" @default.
• W2112775495 hasPublicationYear "2005" @default.
• W2112775495 type Work @default.
• W2112775495 sameAs 2112775495 @default.
• W2112775495 citedByCount "58" @default.
• W2112775495 countsByYear W21127754952012 @default.
• W2112775495 countsByYear W21127754952013 @default.
• W2112775495 countsByYear W21127754952014 @default.
• W2112775495 countsByYear W21127754952015 @default.
• W2112775495 countsByYear W21127754952016 @default.
• W2112775495 countsByYear W21127754952017 @default.
• W2112775495 countsByYear W21127754952018 @default.
• W2112775495 countsByYear W21127754952019 @default.
• W2112775495 countsByYear W21127754952020 @default.
• W2112775495 countsByYear W21127754952021 @default.
• W2112775495 countsByYear W21127754952022 @default.
• W2112775495 countsByYear W21127754952023 @default.
• W2112775495 crossrefType "journal-article" @default.
• W2112775495 hasAuthorship W2112775495A5008224944 @default.
• W2112775495 hasAuthorship W2112775495A5013354704 @default.
• W2112775495 hasAuthorship W2112775495A5034466779 @default.
• W2112775495 hasAuthorship W2112775495A5035081477 @default.
• W2112775495 hasAuthorship W2112775495A5073343840 @default.
• W2112775495 hasConcept C121332964 @default.
• W2112775495 hasConcept C140027455 @default.
• W2112775495 hasConcept C148898269 @default.
• W2112775495 hasConcept C178790620 @default.
• W2112775495 hasConcept C181199279 @default.
• W2112775495 hasConcept C185592680 @default.
• W2112775495 hasConcept C195289149 @default.
• W2112775495 hasConcept C202751555 @default.
• W2112775495 hasConcept C2776524530 @default.
• W2112775495 hasConcept C2777477808 @default.
• W2112775495 hasConcept C2779864607 @default.
• W2112775495 hasConcept C2779907587 @default.
• W2112775495 hasConcept C2781057625 @default.
• W2112775495 hasConcept C29730261 @default.
• W2112775495 hasConcept C41183919 @default.
• W2112775495 hasConcept C43617362 @default.
• W2112775495 hasConcept C55493867 @default.
• W2112775495 hasConcept C56856141 @default.
• W2112775495 hasConcept C62231903 @default.
• W2112775495 hasConcept C62520636 @default.
• W2112775495 hasConcept C87644729 @default.
• W2112775495 hasConceptScore W2112775495C121332964 @default.
• W2112775495 hasConceptScore W2112775495C140027455 @default.
• W2112775495 hasConceptScore W2112775495C148898269 @default.
• W2112775495 hasConceptScore W2112775495C178790620 @default.
• W2112775495 hasConceptScore W2112775495C181199279 @default.
• W2112775495 hasConceptScore W2112775495C185592680 @default.
• W2112775495 hasConceptScore W2112775495C195289149 @default.
• W2112775495 hasConceptScore W2112775495C202751555 @default.
• W2112775495 hasConceptScore W2112775495C2776524530 @default.

• next